BBP-21921 Yellow
Cc1cnc(N(C)c2nc(Nc3cc(C)[nH]n3)cc(C3CC3)n2)c(F)c1
0.458
Platform Score
2D Structure
C18H20FN7 | Exact mass: 353.1764
Key Metrics
-7.4
Vina (kcal/mol)
#748
Docking Rank
1
Hinge Binder
83
TPSA
353
MW
2
HBD
3.7
SlogP
Display Controls
PLK4 Docking Result
-7.41
kcal/mol (molecular docking)
| Docking Rank | #748 of 1,249 |
| Consensus Score | 0.2755 |
| Receptor | PLK4 (PDB: 4YUR) |
| Selective | No |
Selectivity Profile
ADMET Profile
| BBB (BOILED-Egg) | BBB- (non-penetrant) |
| ADMET Status | Pass (no hard fails) |
| hERG Risk | pIC50 0.6 (low risk) |
| AMES Mutagenicity | Negative |
| Efflux Risk (P-gp) | Non-substrate — low efflux risk. ER predicted <2.0 |
| Intestinal Absorption | High |
| 3D PSA | 41.2 A² (CNS-favorable) |
| MDCK Perm (predicted) | -4.75 log Papp (good) |
| CYP3A4 Inhibitor | Inhibitor |
| Hepatotoxicity | Positive |
Flags: ["hepatotox_positive", "CYP3A4_inhibitor"]
CNS Drug-Likeness
Physicochemical Properties
| Molecular Weight | 353.41 Da |
| TPSA | 82.6 A^2 |
| HBD | 2 |
| HBA | 6 |
| SlogP | 3.74 |
| Fsp3 | 0.333 |
| Rotatable Bonds | 5 |
| Rings | 4 (3 aromatic) |
| QED | 0.727 |
| SA Score | 3.10 (1=easy, 10=hard) |
| CNS MPO | 2.60 / 4.0 |
| Formula | C18H20FN7 |
| Exact Mass | 353.1764 |
Classification
| Scaffold (Murcko) | C1CCC(CC2CC(CC3CCCC3)CC(C3CC3)C2)CC1 |
| Source Versions | v17,v33 |
| Best Source Score | 0.7440 |
| Best Source Rank | #184 |
| Hinge Binder | Aminopyrazole DAD |
| InChIKey | UXCLJXBYTUYFLO-UHFFFAOYSA-N |
| Filter Pass | Yes |
Retrosynthetic Analysis
Retrosynthetic analysis not yet run for this compound.
About
Retrosynthetic analysis decomposes the target molecule into purchasable building blocks using learned reaction templates.
A feasible route means the molecule can theoretically be synthesized from commercially available starting materials.
Min steps indicates the shortest synthesis route found.